Proton pump inhibitor use: systematic review of global trends and practices
Abstract Purpose Proton pump inhibitors (PPIs) reduce acid secretion in the stomach and
rank as one of the most widely used acid-suppressing medicines globally. While PPIs are …
rank as one of the most widely used acid-suppressing medicines globally. While PPIs are …
The risks and benefits of long-term use of proton pump inhibitors: expert review and best practice advice from the American Gastroenterological Association
DE Freedberg, LS Kim, YX Yang - Gastroenterology, 2017 - Elsevier
Background & Aims The purpose of this review is to evaluate the risks associated with long-
term use of proton pump inhibitors (PPIs), focusing on long-term use of PPIs for three …
term use of proton pump inhibitors (PPIs), focusing on long-term use of PPIs for three …
KDIGO 2021 clinical practice guideline for the management of glomerular diseases
BH Rovin, SG Adler, J Barratt, F Bridoux… - Kidney …, 2021 - kidney-international.org
Glomerular disease, be it primary or secondary, occurring in the setting of systemic
autoimmune diseases, infections, drugs, or malignancy, affects individuals of all ages. In …
autoimmune diseases, infections, drugs, or malignancy, affects individuals of all ages. In …
High-dimensional characterization of post-acute sequelae of COVID-19
The acute clinical manifestations of COVID-19 have been well characterized,, but the post-
acute sequelae of this disease have not been comprehensively described. Here we use the …
acute sequelae of this disease have not been comprehensively described. Here we use the …
Burdens of post-acute sequelae of COVID-19 by severity of acute infection, demographics and health status
Abstract The Post-Acute Sequelae of SARS-CoV-2 infection (PASC) have been
characterized; however, the burden of PASC remains unknown. Here we used the …
characterized; however, the burden of PASC remains unknown. Here we used the …
[HTML][HTML] Analysis of the Global Burden of Disease study highlights the global, regional, and national trends of chronic kidney disease epidemiology from 1990 to 2016
The last quarter century witnessed significant population growth, aging, and major changes
in epidemiologic trends, which may have shaped the state of chronic kidney disease (CKD) …
in epidemiologic trends, which may have shaped the state of chronic kidney disease (CKD) …
Comparative evaluation of clinical manifestations and risk of death in patients admitted to hospital with covid-19 and seasonal influenza: cohort study
Comparative evaluation of clinical manifestations and risk of death in patients admitted to
hospital with covid-19 and seasonal Page 1 the bmj | BMJ 2020;371:m4677 | doi: 10.1136/bmj.m4677 …
hospital with covid-19 and seasonal Page 1 the bmj | BMJ 2020;371:m4677 | doi: 10.1136/bmj.m4677 …
Safety of proton pump inhibitors based on a large, multi-year, randomized trial of patients receiving rivaroxaban or aspirin
Background & Aims Proton pump inhibitors (PPIs) are effective at treating acid-related
disorders. These drugs are well tolerated in the short term, but long-term treatment was …
disorders. These drugs are well tolerated in the short term, but long-term treatment was …
The 2016 global and national burden of diabetes mellitus attributable to PM2· 5 air pollution
Background PM 2· 5 air pollution is associated with increased risk of diabetes; however, a
knowledge gap exists to further define and quantify the burden of diabetes attributable to PM …
knowledge gap exists to further define and quantify the burden of diabetes attributable to PM …
The risks of long-term use of proton pump inhibitors: a critical review
M Jaynes, AB Kumar - Therapeutic advances in drug safety, 2019 - journals.sagepub.com
Proton pump inhibitors (PPIs) are among the most frequently prescribed medications. Their
use is likely even higher than estimated due to an increase in the number of PPIs available …
use is likely even higher than estimated due to an increase in the number of PPIs available …